Science

Colon Cancer

Feb 3, 2025, 16:23

New Review on ctDNA in Early-Stage Colon Cancer by Rami Yanes et al.

Applonia Rose, Managing Editor at Sage Publishing, shared an article by Rami Yanes, et al. on LinkedIn:

“New Review on Circulating Tumor DNA in Early-Stage Colon Cancer:

Explore the latest review article published in Technology in Cancer Research & Treatment (TCRT), on the prognostic and predictive value of circulating tumor DNA (ctDNA) in early-stage colon cancer. With ctDNA emerging as a promising biomarker, this review examines recent findings, clinical implications and future research needs.

It was a great experience working with Dr. Ibrahim Halil Sahin on this insightful piece. Rami Yanes; University of Pittsburgh School of Medicine.

Read the full article here.”

Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer.

Authors: Rami Yanes, et al.

Applonia Rose cancer Cancer research Colon cancer ctDNA fight against cancer Global fight against cancer Ibrahim Halil Sahin OncoDaily Oncology Rami Yanes Sage Publishing TCRT Technology in Cancer Research & Treatment University of Pittsburgh School of Medicine

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Best of ASCOGI25